Novanta (NASDAQ:NOVT) CFO Sells $200,472.24 in Stock

Novanta Inc. (NASDAQ:NOVT) CFO Robert Buckley sold 1,423 shares of the stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $140.88, for a total transaction of $200,472.24. Following the completion of the sale, the chief financial officer owned 93,814 shares of the company’s stock, valued at approximately $13,216,516.32. The trade was a 1.49% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Robert Buckley also recently made the following trade(s):

• On Wednesday, January 21st, Robert Buckley sold 1,423 shares of Novanta stock. The shares were sold at an average price of $140.14, for a total transaction of $199,419.22.

Novanta Trading Up 2.3%

NASDAQ NOVT opened at $136.25 on Friday. Novanta Inc. has a 1-year low of $98.27 and a 1-year high of $150.18. The company has a current ratio of 3.69, a quick ratio of 1.54 and a debt-to-equity ratio of 0.16. The company has a market capitalization of $4.86 billion, a PE ratio of 93.32 and a beta of 1.62. The firm’s fifty day simple moving average is $133.04 and its 200-day simple moving average is $120.24.

Novanta (NASDAQ:NOVT) last released its quarterly earnings data on Monday, February 23rd. The technology company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.88 by $0.03. Novanta had a return on equity of 13.12% and a net margin of 5.49%.The firm had revenue of $258.35 million during the quarter, compared to analysts’ expectations of $260.72 million. During the same quarter last year, the firm earned $0.76 earnings per share. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q1 2026 guidance at 0.750-0.800 EPS. As a group, sell-side analysts anticipate that Novanta Inc. will post 3.03 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

NOVT has been the subject of a number of recent research reports. Robert W. Baird set a $150.00 price objective on shares of Novanta in a report on Wednesday. Weiss Ratings upgraded Novanta from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday, January 20th. Finally, Zacks Research raised Novanta from a “strong sell” rating to a “hold” rating in a report on Friday, January 16th. Three research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $150.00.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Pilgrim Partners Asia Pte Ltd acquired a new stake in Novanta during the third quarter worth about $36,000. Migdal Insurance & Financial Holdings Ltd. bought a new stake in shares of Novanta in the 3rd quarter worth approximately $40,000. Danske Bank A S acquired a new stake in shares of Novanta during the 3rd quarter worth approximately $40,000. Allworth Financial LP increased its position in shares of Novanta by 978.4% during the fourth quarter. Allworth Financial LP now owns 399 shares of the technology company’s stock valued at $47,000 after purchasing an additional 362 shares during the period. Finally, EverSource Wealth Advisors LLC raised its stake in shares of Novanta by 120.1% in the fourth quarter. EverSource Wealth Advisors LLC now owns 427 shares of the technology company’s stock valued at $51,000 after purchasing an additional 233 shares in the last quarter. Institutional investors and hedge funds own 98.35% of the company’s stock.

Novanta Company Profile

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.